Download free PDF

Indonesia Medical and Wellness Tourism Market Size & Share 2026-2035

Report ID: GMI15639
   |
Published Date: September 2026
 | 
Report Format: PDF/Excel/Dashboard/Platform

Download Free PDF

Explore Our Licensing Options:

Indonesia Medical and Wellness Tourism Market Size

Indonesia's medical and wellness tourism market was valued at USD 7 billion in the base year 2025 and is projected to reach USD 20.6 billion by 2035, expanding at an 11.3% CAGR over the 2026–2035 forecast period.

Indonesia Medical and Wellness Tourism Market Key Takeaways

2025 Market Size
$ 7 Billion
2026 Market Size
$ 7.9 Billion
2035 Forecast Market Size
$ 20.6 Billion
CAGR (2026–2035)
11.3%
Key Players
  • Bali International Hospital, COMO Hotels and Resorts, Fivelements Retreat, Four Seasons Hotels, Gojek, Grab Holdings Ltd., Hilton Worldwide Holdings Inc., InterContinental Group, Marriot International, Radisson Hotel Group, REVIVO Wellness Resort, Rosewood Hotel Group, Siloam Hospitals

Wellness tourism supplies the market's revenue base: it generated USD 6,244.2 million, or 89.6% of market revenue, in 2025 and is expected to reach USD 18,821.5 million in 2035, a CAGR of about 11.5%. Medical tourism was USD 721.1 million in 2025 and is projected at USD 1,827.1 million in 2035. Indonesia's established wellness proposition is rooted in destination assets rather than clinical infrastructure alone; the Global Wellness Institute estimated its wellness economy at USD 56.43 billion in 2024 [1].

The medical component is being shaped by an unusually clear domestic-retention imperative. Indonesian officials have cited more than one million residents travelling overseas for care and approximately USD 11.5 billion of annual foreign-exchange outflow [2]. Sanur Health SEZ in Bali, inaugurated in June 2025, and the Batam International Tourism and Health SEZ, established under Government Regulation No. 39/2024, convert that policy objective into geographically concentrated service platforms. Their commercial relevance depends on whether new clinical capacity earns trust for complex care, not simply on construction completion.

GMI Analyst View

The forecast is principally a wellness-led expansion story, while medical tourism is a capability-building story. Bali's pre-existing appeal shortens the path to wellness revenue because visitors already accept the destination for extended stays and recovery-oriented travel. Medical demand faces a different purchase decision: patients must evaluate clinical outcomes, specialist depth, continuity of care, and accreditation. That difference explains why integrated zones can lift the market's long-run potential but cannot immediately displace established referral patterns toward Singapore and Malaysia.

Sanur and Batam therefore have distinct strategic roles. Sanur can combine a hospital stay with premium recovery accommodation and Bali's mature wellness supply; Batam's proximity to Singapore creates a more direct affordability proposition. The early test is likely to be retention of Indonesian patients seeking check-ups and elective treatment, where travel familiarity and clinical-risk thresholds are lower than for advanced cross-border referrals.

Key Drivers

Driver (~) % Impact on CAGR Forecast Geographic Relevance Impact Timeline
Cost advantage for elective cross-border care +3.2% Primarily Australia, North America, and Western Europe Long term (>4 years)
Government-led health-tourism infrastructure and market access +2.8% Indonesia-wide, concentrated in Bali and Batam Medium term (2–4 years)
Convergence of wellness, prevention, and clinical recovery +2.5% Bali, with spillover to Ubud, Lombok, and Yogyakarta Short term (≤2 years)
Specialist capacity, accreditation, and international clinical partnerships +2.8% Bali, Batam, and Jakarta Medium term (2–4 years)

Cost advantage for elective cross-border care

Indonesia's lower procedure prices can motivate travel where treatment is elective, price transparent, and compatible with a recovery stay. The Business Times reported that Bali providers have attracted Australian cosmetic-surgery patients; BIMC Hospitals Nusa Dua indicated that Australians represented as much as 80% of its international cosmetic-surgery patients [3]. The addressable opportunity is therefore strongest in dental and aesthetic care, where patients can compare packages before travel and the destination's leisure infrastructure reduces the perceived inconvenience of treatment abroad. This table's forecast-impact estimate reflects that demand mechanism and is an analytical estimate, not an observed statistic.

Government-led health-tourism infrastructure and market access

Sanur's integrated model joins clinical facilities with hotels and visitor infrastructure, while Batam's SEZ is designed around cross-border accessibility near Singapore. The Ministry of Tourism is also preparing a medical-tourism catalogue around pilot hospitals, which may make provider discovery and destination promotion more structured for international patients [4]. The benefit is supply-side: coordinated entry, accommodation, and referral pathways can reduce transaction friction. It does not, on its own, establish a hospital's reputation; that remains dependent on delivered clinical quality and specialist availability.

Convergence of wellness, prevention, and clinical recovery

Bali's wellness operators already package multi-day programmes around nutrition, movement, traditional therapies, and recovery services. COMO Shambhala Estate offers Ayurvedic and Traditional Chinese Medicine consultations alongside therapies including hyperbaric oxygen and contrast treatments; REVIVO's Vitality Centre combines diagnostics, regenerative aesthetics, and nutrition-led wellness programming. The commercial effect is not merely a broader service menu. It enables providers to convert a hotel booking into a longer, higher-value programme and gives clinical visitors a more credible recovery itinerary, provided operators do not blur the distinction between hospitality wellness and regulated medical care.

Specialist capacity, accreditation, and international clinical partnerships

International partnerships address a central medical-tourism constraint: patients cannot readily observe clinical quality before travelling. Bali International Hospital's heart-centre collaboration with HK Asia Medical Group is intended to bring cardiovascular capability, equipment, and professional development into the Sanur platform. Siloam's history of Joint Commission International recognition similarly provides an externally legible quality signal. In Batam, Mayapada Healthcare's planned 250-bed hospital, developed with Apollo Hospitals as a strategic partner, is intended to cover cardiovascular, oncology, neurology, gastrohepatology, and orthopedics. The impact estimate reflects the time needed for these inputs to translate into outcomes and referrals.

Key Restraints

Restraint (~) % Impact on CAGR Forecast Geographic Relevance Impact Timeline
Entrenched regional referral hubs in Thailand, Malaysia, and Singapore -2.5% Indonesia versus ASEAN regional market Long term (>4 years)

Entrenched regional referral hubs

Indonesia competes against systems that already command patient familiarity, specialist reputations, and referral networks. Thailand recorded 2.86 million international patients and about USD 850 million in medical-tourism revenue in 2023, while Malaysia generated more than RM2 billion from medical tourism that year [5]. A 2024 review of Indonesian medical tourism identifies Malaysia and Singapore as major destinations for Indonesian patients, illustrating the persistence of outbound trust patterns.

The restraint is most material in high-acuity care. Patients can more readily substitute a dental implant or an aesthetic procedure across destinations than an oncology or cardiovascular pathway that requires diagnostic confidence and follow-up. New SEZs may improve Indonesia's relative proposition, but construction, a partnership announcement, and an operating record are not equivalent. The -2.5% figure is a calibrated forecast-impact estimate based on this long-standing competitive disadvantage.

GMI Analyst View

Demand drivers and competitive constraints operate on different clocks. Wellness and elective-care demand can respond relatively quickly to travel convenience, price, and packaged recovery experiences. In contrast, medical-tourism share in complex specialties accumulates through repeat outcomes, clinician networks, and accreditation, all of which develop more slowly. Indonesia's forecast consequently relies on wellness for continuity and on hospital-platform execution for incremental medical upside.

This places unusual value on operational integration. Sanur and Batam must make arrival, diagnosis, treatment, accommodation, and post-discharge coordination feel coherent without overstating clinical capability. A fragmented handoff would preserve the appeal of Malaysia, Singapore, and Thailand; credible service continuity could make Indonesia's cost and destination advantages more actionable.

Indonesia Medical and Wellness Tourism Market Segment Analysis

Wellness tourism

Wellness activities are the segment's experiential core. Retreat programmes built around yoga, meditation, therapeutic cuisine, and Balinese healing can use Ubud's and Bali's cultural setting as part of the service itself. COMO and REVIVO demonstrate the premium end of this offer, where personalized programmes and diagnostics are bundled with accommodation rather than sold as isolated spa treatments. That structure favors longer stays and makes service design, practitioner availability, and programme credibility more important than room inventory alone.

Indonesia Medical and Wellness Tourism Market, By Category, 2022-2035 (USD Billion)

Transport is a supporting revenue stream and a practical access layer. Gojek's GoMed combines healthcare access features with the wider super-app ecosystem [6], while GrabHealth, powered by Good Doctor, offers digital healthcare access and appointment-related services. For tourism providers, such platforms can reduce friction around local mobility, medicine delivery, and pre- or post-visit contact; they should not be treated as substitutes for international clinical coordination.

Lodging captures a substantial share of wellness-trip spend because the programme is delivered over multiple nights. Four Seasons operates wellness and spa facilities in Ubud, while the Sanur zone incorporates Meru Sanur and Bali Beach Hotel alongside its clinical anchor. This adjacency matters for medical recovery as well as wellness: it can extend stays and simplify transfers, but the revenue model requires accommodation partners to align privacy, dietary, mobility, and caregiver needs with hospital discharge planning. Other services include nutrition, wellness retail, traditional Jamu-linked offerings, workshops, and digital follow-up.

Medical tourism

Cosmetic surgeries, including breast augmentation, hair transplant, and other procedures, are positioned for earlier inbound adoption because consumers can compare providers and combine a planned recovery period with a Bali visit. Dental treatments, spanning implants, orthodontics, cosmetics, prosthetics, and other dental care, share this advantage: treatment is often price-sensitive and can be staged around travel. The Australian patient mix reported by BIMC underscores the importance of proximity and established destination familiarity in these applications.

Cardiovascular surgery and oncology treatment depend more heavily on specialist depth, diagnostics, and institutional reputation. Bali International Hospital's partnership with HK Asia Medical Group and its relationships with international medical partners support the development of cardiovascular and oncology capability. Orthopedic surgery, including knee replacement, hip replacement, spinal surgeries, shoulder replacement, ankle replacement, and other orthopedic procedures, is also included in the planned Mayapada Apollo Batam hospital's specialty mix. These services may expand the addressable market, but their tourism potential is conditional on outcome data, care pathways, and follow-up arrangements.

Bariatric surgery and fertility treatment remain part of the application scope, alongside preventive screening, ophthalmology, geriatric care, and other applications. Their commercialization is likely to be shaped by clinical governance, cultural considerations, and the availability of specialist pathways rather than destination branding alone. Across medical applications, the near-term mix should favor services with clear consumer choice and manageable continuity requirements; higher-acuity categories require earned trust rather than promotional reach.

GMI Analyst View

The segment split reveals two different monetization models. Wellness creates value by extending and enriching the visitor stay; medical tourism creates value when a provider can reduce perceived clinical risk enough for a patient to travel. The first model is already reinforced by Bali's accommodation and retreat ecosystem. The second is concentrated in applications where the hospital can demonstrate specialist capability and coordinate care beyond discharge.

Dental and cosmetic procedures can provide an entry point because their purchase process is comparatively consumer-led. Cardiovascular, oncology, and major orthopedic care offer larger strategic upside, yet they also expose providers to the highest evidence, referral, and continuity-of-care threshold. Partnerships and SEZ infrastructure may narrow that gap, but they should be assessed as capability investments rather than evidence of immediately transferable patient volumes.

Indonesia Medical and Wellness Tourism Market Share & Competitive Landscape

Competition spans hospitals, luxury and specialist wellness resorts, hotel groups, and digital access platforms. Bali International Hospital and Siloam Hospitals are the principal clinical names within the authorized company scope. BIH is the Sanur SEZ's clinical anchor and is developing international specialist relationships; Siloam contributes a larger domestic network and internationally recognized quality credentials. Their ability to convert infrastructure and accreditation into international patient confidence will determine whether medical tourism becomes a larger share of market value.

COMO Hotels and Resorts, Fivelements Retreat, Four Seasons Hotels, REVIVO Wellness Resort, Rosewood Hotel Group, Marriott International, Hilton Worldwide Holdings Inc., InterContinental Group, and Radisson Hotel Group compete through accommodation, programme design, brand distribution, and recovery suitability. COMO's Ubud estate and REVIVO's Vitality Centre illustrate differentiated, programme-led wellness offers. Four Seasons expanded its Sayan wellness facilities with a Fitness Hub in August 2025. Hilton has signed a Waldorf Astoria Bali project, and InterContinental operates resort assets in Bali and Sanur, adding international lodging brands to the recovery-hospitality ecosystem. Fivelements' acquisition by GOCO Hospitality points to continuing investor interest in Bali's premium wellness assets [7].

Gojek and Grab Holdings Ltd. occupy an enabling position. GoMed and GrabHealth can support appointment access, medication fulfillment, and local service coordination. Their relevance to tourism is operational rather than clinical: digital convenience can improve the visitor journey, but providers remain responsible for medical records, consent, escalation, and cross-border follow-up. No single company spans every part of the journey, so hospital-resort-digital partnerships are likely to remain a central route to differentiated service delivery.

Recent Industry Developments

March 2026 - Siloam Hospitals Bali received its third consecutive JCI re-accreditation.

The renewal reinforced an international quality signal for a Bali provider serving international patients.

December 2025 - GOCO Hospitality acquired Fivelements Retreat Bali.

The buyer indicated plans to relaunch the property with expanded longevity and wellness programming.

October 2025 - Hilton announced further luxury and lifestyle development in Southeast Asia, including Waldorf Astoria Bali.

The announced Bali property comprises 71 villas and 68 suites and is expected to open in early 2029.

August 2025 - Mayapada Healthcare commenced its Batam international-hospital project.

The planned 250-bed facility is intended to operate within the Batam health-tourism SEZ, with Apollo Hospitals as strategic partner.

August 2025 - Four Seasons Resort Bali at Sayan launched its Fitness Hub.

The development expanded the property's wellness facilities and recovery-oriented offer.

June 2025 - Indonesia inaugurated Sanur Health SEZ.

The zone brought Bali International Hospital, hotels, and supporting visitor infrastructure into Indonesia's first integrated health-tourism complex.

October 2024 - Government Regulation No. 39/2024 established the Batam International Tourism and Health SEZ.

The measure created the regulatory platform for health-tourism development in Sekupang and Nongsa.

Indonesia Medical and Wellness Tourism Market Research Report.webp

Need a specific section of this report?

Purchase regional analysis, country-level analysis, company profiles, or any other segment-level insights separately
based on your research needs.

Authors:  Mariam Faizullabhoy, Mayur Shinde

Table of Contents

Chapter 1   Research Methodology

Chapter 2   Executive Summary

Chapter 3   Industry Insights

Chapter 4   Competitive Landscape, 2025

Chapter 5   Market Estimates and Forecast, By Category, 2022 - 2035 ($ Mn)

Chapter 6   Healthcare and Wellness Providers

Frequently Asked Question(FAQ) :
How big is the indonesia medical and wellness tourism market?
The indonesia medical and wellness tourism market size was estimated at USD 7 billion in 2025 and is expected to reach USD 7.9 billion in 2026.
What is the 2035 forecast for the indonesia medical and wellness tourism market?
The market is projected to reach USD 20.6 billion by 2035, growing at a CAGR of 11.3% from 2026 to 2035.

Research methodology, data sources & validation process

This report draws on a structured research process built around direct industry conversations, proprietary modelling, and rigorous cross-validation and not just desk research.

Our 6-step research process

  1. 1. Research design & analyst oversight

    At GMI, our research methodology is built on a foundation of human expertise, rigorous validation, and complete transparency. Every insight, trend analysis, and forecast in our reports is developed by experienced analysts who understand the nuances of your market.

    Our approach integrates extensive primary research through direct engagement with industry participants and experts, complemented by comprehensive secondary research from verified global sources. We apply quantified impact analysis to deliver dependable forecasts, while maintaining complete traceability from original data sources to final insights.

  2. 2. Primary research

    Primary research forms the backbone of our methodology, contributing nearly 80% to overall insights. It involves direct engagement with industry participants to ensure accuracy and depth in analysis. Our structured interview program covers regional and global markets, with inputs from C-suite executives, directors, and subject matter experts. These interactions provide strategic, operational, and technical perspectives, enabling well-rounded insights and reliable market forecasts.

  3. 3. Data mining & market analysis

    Data mining is a key part of our research process, contributing nearly 20% to the overall methodology. It involves analysing market structure, identifying industry trends, and assessing macroeconomic factors through revenue share analysis of major players. Relevant data is collected from both paid and unpaid sources to build a reliable database. This information is then integrated to support primary research and market sizing, with validation from key stakeholders such as distributors, manufacturers, and associations.

  4. 4. Market sizing

    Our market sizing is built on a bottom-up approach, starting with company revenue data gathered directly through primary interviews, alongside production volume figures from manufacturers and installation or deployment statistics. These inputs are then pieced together across regional markets to arrive at a global estimate that stays grounded in actual industry activity.

  5. 5. Forecast model & key assumptions

    Every forecast includes explicit documentation of:

    • ✓ Key growth drivers and their assumed impact

    • ✓ Restraining factors and mitigation scenarios

    • ✓ Regulatory assumptions and policy change risk

    • ✓ Technology adoption curve parameter

    • ✓ Macroeconomic assumptions (GDP growth, inflation, currency)

    • ✓ Competitive dynamics and market entry/exit expectations

  6. 6. Validation & quality assurance

    The final stages involve human validation, where domain experts manually review filtered data to identify nuances and contextual errors that automated systems might miss. This expert review adds a critical layer of quality assurance, ensuring data aligns with research objectives and domain-specific standards.

    Our triple-layer validation process ensures maximum data reliability:

    • ✓ Statistical Validation

    • ✓ Expert Validation

    • ✓ Market Reality Check

Trust & credibility

10+
Years in Service
Consistent delivery since establishment
A+
BBB Accreditation
Professional standards & satisfaction
ISO
Certified Quality
ISO 9001-2015 Certified Company
150+
Research Analysts
Across 20+ industry verticals
95%
Client Retention
5-year relationship value

Verified data sources

  • Trade publications

    Industry journals, trade publications, and specialized media.

  • Industry databases

    Proprietary and third-party market databases

  • Regulatory filings

    Government procurement records and policy documents

  • Academic research

    University studies and specialist institution reports

  • Company reports

    Annual reports, investor presentations, and filings

  • Expert interviews

    C-suite, procurement leads, and technical specialists

  • GMI archive

    13,000+ published studies across 20+ industry verticals

  • Trade data

    Import/export volumes, HS codes, and customs records

Parameters studied & evaluated

Every data point in this report is validated through primary interviews, true bottom-up modelling, and rigorous cross-checks. Read about our research process →

Authors:  Mariam Faizullabhoy, Mayur Shinde
We use cookies to enhance user experience. (Privacy Policy)